Cryoport, Inc. (CYRX) Q3 2025 Earnings Call Transcript
Cryoport, Inc. ( CYRX ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Jerrell Shelton - Chairman, President & CEO Robert Stefanovich - Senior VP, CFO, Treasurer & Chief Administrative Officer Mark W. Sawicki - Senior VP & Chief Scientific Officer Thomas Heinzen - Vice President of Corporate Development & Investor Relations Conference Call Participants Todd Fromer - Kanan, Corbin, Schupak & Aronow, Inc. Kyle Crews - UBS Investment Bank, Research Division David Saxon - Needham & Company, LLC, Research Division Puneet Souda - Leerink Partners LLC, Research Division Matthew Stanton - Jefferies LLC, Research Division Subhalaxmi Nambi - Guggenheim Securities, LLC, Research Division David Larsen - BTIG, LLC, Research Division Mason Carrico - Stephens Inc., Research Division Presentation Operator " Jerrell Shelton Chairman, President & CEO " Robert Stefanovich Senior VP, CFO, Treasurer & Chief Administrative Officer " Mark W.
CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.02 per share a year ago.
Cryoport, Inc. (CYRX) Q2 2025 Earnings Call Transcript
Cryoport, Inc. (NASDAQ:CYRX ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Jerrell W. Shelton - Chairman, President & CEO Mark W.
CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.33 per share a year ago.
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoPort, Inc. (CYRX) Just Flashed Golden Cross Signal: Do You Buy?
CryoPort, Inc. (CYRX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CYRX's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
What Makes CryoPort, Inc. (CYRX) a Strong Momentum Stock: Buy Now?
Does CryoPort, Inc. (CYRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know
CryoPort (CYRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Believe CryoPort (CYRX) Could Rally 81.43%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 81.4% in CryoPort (CYRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect?
The mean of analysts' price targets for CryoPort (CYRX) points to a 54.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.43 per share a year ago.
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
